Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-13

Clinical Trial Update: Effect of Acetazolamide on Acute Mountain Sickness in Lowlanders Older Than 40 Years [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of acetazolamide on acute mountain sickness in adults over 40 years old has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Acute Mountain Sickness | Phase 4 | Status: COMPLETED